IT1286510B1 - Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono - Google Patents

Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono

Info

Publication number
IT1286510B1
IT1286510B1 IT96MI002505A ITMI962505A IT1286510B1 IT 1286510 B1 IT1286510 B1 IT 1286510B1 IT 96MI002505 A IT96MI002505 A IT 96MI002505A IT MI962505 A ITMI962505 A IT MI962505A IT 1286510 B1 IT1286510 B1 IT 1286510B1
Authority
IT
Italy
Prior art keywords
pct
pharmaceutical compositions
date
contain
esters
Prior art date
Application number
IT96MI002505A
Other languages
English (en)
Inventor
Alberto Perbellini
Danila Coradini
Original Assignee
Cooperativa Centro Ricerche Po
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooperativa Centro Ricerche Po filed Critical Cooperativa Centro Ricerche Po
Publication of ITMI962505A0 publication Critical patent/ITMI962505A0/it
Priority to IT96MI002505A priority Critical patent/IT1286510B1/it
Priority to CA002272720A priority patent/CA2272720C/en
Priority to AT97953702T priority patent/ATE241648T1/de
Priority to US09/308,832 priority patent/US6140313A/en
Priority to AU57515/98A priority patent/AU5751598A/en
Priority to EP97953702A priority patent/EP0941253B1/en
Priority to DE69722434T priority patent/DE69722434T2/de
Priority to JP52427698A priority patent/JP4256475B2/ja
Priority to PCT/EP1997/006589 priority patent/WO1998023648A1/en
Publication of ITMI962505A1 publication Critical patent/ITMI962505A1/it
Application granted granted Critical
Publication of IT1286510B1 publication Critical patent/IT1286510B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT96MI002505A 1996-11-29 1996-11-29 Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono IT1286510B1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT96MI002505A IT1286510B1 (it) 1996-11-29 1996-11-29 Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
AU57515/98A AU5751598A (en) 1996-11-29 1997-11-26 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
AT97953702T ATE241648T1 (de) 1996-11-29 1997-11-26 Buttersäure-ester mit antiproliferativer wirkung und diese enthaltende pharmazeutische zusammensetzungen
US09/308,832 US6140313A (en) 1996-11-29 1997-11-26 Butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
CA002272720A CA2272720C (en) 1996-11-29 1997-11-26 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
EP97953702A EP0941253B1 (en) 1996-11-29 1997-11-26 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
DE69722434T DE69722434T2 (de) 1996-11-29 1997-11-26 Buttersäure-ester mit antiproliferativer wirkung und diese enthaltende pharmazeutische zusammensetzungen
JP52427698A JP4256475B2 (ja) 1996-11-29 1997-11-26 抗増殖活性を有する新規な酪酸エステルおよびこれを含む薬剤組成物
PCT/EP1997/006589 WO1998023648A1 (en) 1996-11-29 1997-11-26 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI002505A IT1286510B1 (it) 1996-11-29 1996-11-29 Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
ITMI962505A0 ITMI962505A0 (it) 1996-11-29
ITMI962505A1 ITMI962505A1 (it) 1998-05-29
IT1286510B1 true IT1286510B1 (it) 1998-07-15

Family

ID=11375310

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI002505A IT1286510B1 (it) 1996-11-29 1996-11-29 Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono

Country Status (9)

Country Link
US (1) US6140313A (it)
EP (1) EP0941253B1 (it)
JP (1) JP4256475B2 (it)
AT (1) ATE241648T1 (it)
AU (1) AU5751598A (it)
CA (1) CA2272720C (it)
DE (1) DE69722434T2 (it)
IT (1) IT1286510B1 (it)
WO (1) WO1998023648A1 (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1140198T3 (da) 1999-01-13 2008-03-10 Alchemia Oncology Pty Ltd Anvendelse af hyaluronan til fremstilling af et lægemiddel til forögelse af cytotoksiske lægemidlers virkningsgrad
IT1318403B1 (it) 2000-03-17 2003-08-25 Cooperativa Ct Ricerche Poly T Esteri polisaccaridici di n-derivati di acido glutammico.
US9066919B2 (en) 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
AUPQ879500A0 (en) 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
CN1492877A (zh) * 2001-02-20 2004-04-28 �����﹤����ʽ���� 修饰剂
ITTS20010013A1 (it) * 2001-06-04 2002-12-04 Ct Ricerche Poly Tec H A R L S Nuovi derivati di ialuronano.
ITTS20010017A1 (it) * 2001-07-17 2003-01-17 Ct Ricerche Polytech Soc Coop Esteri polisaccaridici di acido retinoico.
ITMI20022745A1 (it) * 2002-12-23 2004-06-24 Coimex Scrl United Companies Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione.
ITMI20040605A1 (it) * 2004-03-29 2004-06-29 Coimex S C R L United Companie Esteri butirrici dell'acido ialuronico a basso grado di sostituzione procedimento per la loro preparazione ed uso
JP5465431B2 (ja) 2005-07-27 2014-04-09 アルケミア オンコロジー ピーティーワイ リミテッド ヒアルロナンを用いる治療プロトコル
WO2007028196A1 (en) 2005-09-07 2007-03-15 Alchemia Oncology Pty Limited Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
CA2621595A1 (en) * 2005-09-21 2007-04-12 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides
ATE454908T1 (de) * 2005-09-21 2010-01-15 Surmodics Inc In situ okklusionszusammensetzungen mit natürlichen biologisch abbaubaren polysacchariden
US7993678B2 (en) * 2005-09-26 2011-08-09 Novozymes Biopolymer A/S Hyaluronic acid derivatives
DE102005046237A1 (de) * 2005-09-28 2007-04-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
US20080154241A1 (en) * 2006-12-07 2008-06-26 Burkstrand Michael J Latent stabilization of bioactive agents releasable from implantable medical articles
EP1942117A1 (en) * 2006-12-29 2008-07-09 Sigea S.R.L. Derivatives of acid polysaccharides
ITMI20072237A1 (it) * 2007-11-27 2009-05-28 Sigea Srl Esteri misti butirrico-formico di polisaccaridi acidi, loro preparazione ed uso come dermocosmetici
US20150299339A1 (en) * 2012-11-14 2015-10-22 National Institute Of Advanced Industrial Science And Technology Beta-1,3-glucan derivative and method for producing beta-1,3-glucan derivative
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
US10618982B2 (en) * 2015-01-13 2020-04-14 Bmg Pharma S.P.A. Process in water for the preparation of butyric esters of hyaluronic acid sodium salt
IT201900021693A1 (it) 2019-11-20 2021-05-20 Bmg Pharma S P A Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione
IT202000016984A1 (it) 2020-07-13 2022-01-13 Bmg Pharma S P A Composizioni igienizzanti e antiinfettive per le mucose orali

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU497159B2 (en) * 1974-02-21 1978-12-07 Commonwealth Scientific And Industrial Research Organization Removing limonin from citrus fruit juice
EP0256880B1 (en) * 1986-08-20 1995-05-03 Miami University Alkanoyl esters of heparin of low molecular weight
FR2633929B2 (fr) * 1987-09-25 1995-05-24 Picardie Universite Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
US4959466A (en) * 1988-01-25 1990-09-25 Arco Chemical Technology, Inc. Partially esterified polysaccharide (PEP) fat substitutes
EP0330106A1 (de) * 1988-02-25 1989-08-30 Akzo Nobel N.V. Modifizierte Cellulose für biocompatible Dialysemembranen II und Verfahren zu deren Herstellung
JP2667441B2 (ja) * 1988-05-18 1997-10-27 生化学工業株式会社 血管内皮細胞増殖抑制剤
FR2634485B1 (fr) * 1988-07-21 1992-02-28 Sanopi Glycosaminoglycanes selectivement o-acyles, leur preparation et compositions pharmaceutiques les contenant
EP0477347B1 (en) * 1990-04-16 1996-06-19 Eastman Chemical Company Process for preparing cellulose esters by use of carboxylic acids
WO1994008617A1 (en) * 1992-10-16 1994-04-28 Brigham And Women's Hospital, Inc. O-derivatized alginic acid antigens
DE4414138A1 (de) * 1994-04-22 1995-10-26 Consortium Elektrochem Ind Acylierte gamma-Cyclodextrine
FR2723096B1 (fr) * 1994-07-28 1996-10-18 Univ Picardie Esters associant les acides phenylacetique,3-phenyl-propionique, 4-phenyl-butyrique et n-butyrique au d-mannose, au xylitol et a leurs derives. applications comme medicaments
DE69520951T2 (de) * 1994-10-28 2001-11-22 Novozymes A/S, Bagsvaerd Verfahren zur chemischen ausrüstung von unlöslichen polymerfasern
DE19529409A1 (de) * 1995-08-10 1997-02-13 Wolff Walsrode Ag Maleinsäureadditionsproduktgruppen enthaltende, thermoplastische und biologisch abbaubare Polysaccharidester/-etherester
DE19607847C1 (de) * 1996-03-01 1997-11-20 Suedzucker Ag Aliphatische Carbonsäureester von Inulin
US5916883A (en) * 1996-11-01 1999-06-29 Poly-Med, Inc. Acylated cyclodextrin derivatives

Also Published As

Publication number Publication date
DE69722434T2 (de) 2004-04-08
EP0941253A1 (en) 1999-09-15
US6140313A (en) 2000-10-31
JP4256475B2 (ja) 2009-04-22
DE69722434D1 (de) 2003-07-03
CA2272720A1 (en) 1998-06-04
ITMI962505A0 (it) 1996-11-29
EP0941253B1 (en) 2003-05-28
ITMI962505A1 (it) 1998-05-29
AU5751598A (en) 1998-06-22
CA2272720C (en) 2008-01-08
ATE241648T1 (de) 2003-06-15
WO1998023648A1 (en) 1998-06-04
JP2001505940A (ja) 2001-05-08

Similar Documents

Publication Publication Date Title
IT1286510B1 (it) Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
PT841898E (pt) COMPOSICOES TóPICAS QUE PROPORCIONAM UMA MELHOR SENSACAO DA PELE
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
FR2714830B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
PL315684A1 (en) Biodegradable 3-polyhydroxybutyrate/3-polyhydroxyhaxanate copolymer
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
NO971192L (no) Fremgangsmåter for avlevering av materialer inn i huden, og sammensetninger som blir anvendt
CA2289717A1 (en) Novel therapy for constipation
IL114586A (en) Droloxifene for use in the treatment of cardiovascular diseases and pharmaceutical compositions comprising same
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
IT1263013B (it) Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
MX9603596A (es) Perfluoropolieteres o composiciones de los mismos para prevencion y tratamiento de infecciones virales topicas.
PL330865A1 (en) Agents containing lectins and their application
SE9401540D0 (sv) Munhygienkomposition
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
PH27214A (en) N-2,3-butadienyl tri and tetraaminoalkane derivatives
CA2094275A1 (en) Methods and compositions for the treatment of cell proliferation disorders
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
DE69323191D1 (de) Wasserlösliche retinoide
CA2238871A1 (en) Method of using beta-interferons to treat restenosis
ITMI922657A1 (it) Composizione terapeutica per uso rettale a base di flunisolide e/o dei relativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
MY113423A (en) Substituted thiophenesulfonylureas and -thioureas processes for their preparation, their use as amedicament or diagnostic, and medicament contiaining them
PT99238A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um inibidor da enzima conversora da angiotensina e um inibidor da actividade do tromboxano a2, utilizadas no tratamento de nefropatias

Legal Events

Date Code Title Description
0001 Granted